Lantheus Holdings, Inc. (LNTH) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$86.15
Price Target
$101.00
Target Range
$95.00 — $110.00
Analyst Rating
Buy
Forward P/E16.6x
Trailing P/E25.3x
Forward PEG—
Implied Growth+47.5%
Median Target$98.00
Analyst Spread14.9%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$95
+10.3%
Consensus
$101
+17.2%
Bull Case
$110
+27.7%
LNTH Price Target Analysis
Updated May 6, 2026As of May 6, 2026, Lantheus Holdings, Inc. (LNTH) has a Wall Street consensus price target of $101.00, based on estimates from 17 covering analysts. With the stock currently trading at $86.15, this represents a potential upside of +17.2%. The company has a market capitalization of $5.61B.
Analyst price targets range from a low of $95.00 to a high of $110.00, representing a 15% spread in expectations. The median target of $98.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 13 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, LNTH trades at a trailing P/E of 25.3x and forward P/E of 16.6x. Analysts expect EPS to grow +47.5% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+31.1%
Avg Forward P/E89.1x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 RMDResMed Inc. | $30.5B | $209.64 | $281.29 | +34.2% | Buy | 19.0x | 35 |
 BWXTBWX Technologies, Inc. | $19.7B | $215.20 | $210.00 | -2.4% | Buy | 46.7x | 16 |
 EXASExact Sciences Corporation | $20.0B | $104.91 | $103.18 | -1.6% | Buy | 582.8x | 41 |
 ROIVRoivant Sciences Ltd. | $20.9B | $28.82 | $33.20 | +15.2% | Buy | — | 14 |
 GEGE Aerospace | $319.5B | $305.83 | $386.20 | +26.3% | Buy | 40.4x | 34 |
 GEHCGE HealthCare Technologies Inc. | $28.1B | $61.73 | $84.00 | +36.1% | Buy | 12.5x | 18 |
 MDTMedtronic plc | $99.5B | $77.60 | $109.50 | +41.1% | Buy | 14.1x | 49 |
 ISRGIntuitive Surgical, Inc. | $160.4B | $451.73 | $622.60 | +37.8% | Buy | 43.7x | 55 |
 NVSTEnvista Holdings Corp | $4.5B | $27.06 | $27.00 | -0.2% | Hold | 19.2x | 19 |
 PODDInsulet Corporation | $10.6B | $151.17 | $339.00 | +124.3% | Buy | 23.8x | 50 |
Upside Potential Comparison
PODDMDTISRGGEHCRMDGEROIVNVSTSee LNTH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LNTH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LNTH vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLNTH — Frequently Asked Questions
Quick answers to the most common questions about buying LNTH stock.
What is the LNTH stock price target for 2026?
Lantheus Holdings, Inc. (LNTH) has a consensus 12-month price target of $101, implying 17.2% upside from $86.15. The 17 analysts covering LNTH see moderate appreciation potential.
Is LNTH a buy, sell, or hold?
LNTH has a consensus rating of "Buy" based on 17 Wall Street analysts. The rating breakdown is predominantly bullish, with 13 Buy/Strong Buy ratings. The consensus 12-month price target of $101 implies 17.2% upside from current levels.
Is LNTH stock overvalued or undervalued?
With a forward P/E of 16.5861x, LNTH trades at a relatively low valuation. The consensus target of $101 implies 17.2% appreciation, suggesting meaningful undervaluation.
How high can LNTH stock go?
The most bullish Wall Street analyst has a price target of $110 for LNTH, while the most conservative target is $95. The consensus of $101 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover LNTH stock?
LNTH is well covered by analysts, with 17 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 13 have Buy ratings, 4 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the LNTH stock forecast?
The 12-month LNTH stock forecast based on 17 Wall Street analysts shows a consensus price target of $101, with estimates ranging from $95 (bear case) to $110 (bull case). The median consensus rating is "Buy".
What is LNTH's forward P/E ratio?
LNTH trades at a forward P/E ratio of 16.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 25.3x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy LNTH stock?
Wall Street analysts are optimistic on LNTH, with a "Buy" consensus rating and $101 price target (17.2% upside). 13 of 17 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do LNTH price targets vary so much?
LNTH analyst price targets range from $95 to $110, a 15% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $101 consensus represents the middle ground.